CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Assembly Biosciences, Inc. - ASMB CFD

    1.0873
    1.84%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 0.0554
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.025457%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.003235%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    Assembly Biosciences Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    关键数据
    前收盘价* 1.0677
    开仓* 1.0677
    1 年变化* -45.25%
    日范围* 1.0282 - 1.0873
    52 周范围 0.77-2.42
    平均交易量（10 天） 169.49K
    平均交易量（3 个月) 4.66M
    市值 57.33M
    市盈率 -100.00K
    流通股 52.12M
    收入 N/A
    EPS -1.81
    股息（收益率 %） N/A
    贝塔 0.70
    下一个财报发布日期 Aug 7, 2023

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low
    Jun 6, 2023 1.0677 0.0296 2.85% 1.0381 1.0872 1.0381
    Jun 5, 2023 1.0774 0.0294 2.81% 1.0480 1.1558 1.0471
    Jun 2, 2023 1.0676 0.1168 12.28% 0.9508 1.1167 0.9107
    Jun 1, 2023 0.9274 -0.0024 -0.26% 0.9298 0.9534 0.9009
    May 31, 2023 0.9323 0.0025 0.27% 0.9298 0.9695 0.9298
    May 30, 2023 0.9302 -0.0001 -0.01% 0.9303 0.9991 0.9207
    May 26, 2023 0.9451 -0.0144 -1.50% 0.9595 0.9697 0.9251
    May 25, 2023 0.9519 -0.0471 -4.71% 0.9990 0.9990 0.9302
    May 24, 2023 0.9990 -0.0294 -2.86% 1.0284 1.0677 0.9892
    May 23, 2023 1.0383 0.0494 5.00% 0.9889 1.0677 0.9889
    May 22, 2023 1.0578 0.0687 6.95% 0.9891 1.0677 0.9794
    May 19, 2023 1.0187 0.0297 3.00% 0.9890 1.0187 0.9794
    May 18, 2023 0.9893 0.0300 3.13% 0.9593 0.9893 0.9506
    May 17, 2023 0.9893 0.0101 1.03% 0.9792 0.9893 0.9302
    May 16, 2023 0.9794 -0.0196 -1.96% 0.9990 0.9990 0.9304
    May 15, 2023 1.0187 0.0398 4.07% 0.9789 1.0285 0.9789
    May 12, 2023 1.0187 0.0104 1.03% 1.0083 1.0480 0.9794
    May 11, 2023 1.0285 0.0301 3.01% 0.9984 1.0775 0.9984
    May 10, 2023 1.0775 0.0593 5.82% 1.0182 1.0775 1.0182
    May 9, 2023 1.0480 0.0692 7.07% 0.9788 1.0579 0.9788

    Assembly Biosciences, Inc. Events

    时间（协调世界时） (UTC) 国家/地区 事件
    Monday, August 7, 2023

    时间（协调世界时） (UTC)

    10:59

    国家/地区

    US

    事件

    Q2 2023 Assembly Biosciences Inc Earnings Release
    Q2 2023 Assembly Biosciences Inc Earnings Release

    Forecast

    -

    Previous

    -
    Monday, November 6, 2023

    时间（协调世界时） (UTC)

    10:59

    国家/地区

    US

    事件

    Q3 2023 Assembly Biosciences Inc Earnings Release
    Q3 2023 Assembly Biosciences Inc Earnings Release

    Forecast

    -

    Previous

    -
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 0 6.254 79.105 15.963 14.804
    总营业费用 94.114 138.942 143.881 118.676 107.539
    销售/一般/行政费用，总计 23.906 28.503 36.86 32.919 34.798
    研究与开发 69.111 70.149 101.337 85.757 72.741
    营业收入 -94.114 -132.688 -64.776 -102.713 -92.735
    利息收入（费用），非经营净值 1.022 0.302 2.624 4.3 3.083
    税前净收入 -93.092 -132.386 -62.152 -98.408 -89.652
    税后净收入 -93.092 -129.855 -62.152 -97.634 -90.751
    未计算非常项目前的净收益 -93.092 -129.855 -62.152 -97.634 -90.751
    净收入 -93.092 -129.855 -62.152 -97.634 -90.751
    普通股股东可获收益 (不含非经常性项目) -93.092 -129.855 -62.152 -97.634 -90.751
    普通股股东可获收益 (含非經常性項目) -93.092 -129.855 -62.152 -97.634 -90.751
    摊薄净收入 -93.092 -129.855 -62.152 -97.634 -90.751
    摊薄后加权平均股 48.4093 43.2804 35.4271 26.2588 22.8016
    扣除特别项目的每股摊薄盈利 -1.92302 -3.00032 -1.75436 -3.71815 -3.98002
    每股正常摊薄盈利 -1.90036 -2.39523 -1.59392 -3.71815 -3.98002
    收入 0 6.254 79.105 15.963 14.804
    非常规项目总计
    其他，净值 0.005
    异常费用（收入） 1.097 40.29 5.684
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    总收入 0 0 0 0 0
    收入 0 0
    总营业费用 19.559 22.978 23.401 24.573 23.162
    销售/一般/行政费用，总计 5.012 5.897 5.271 6.781 5.957
    研究与开发 14.547 15.984 18.13 17.792 17.205
    异常费用（收入） 1.097
    营业收入 -19.559 -22.978 -23.401 -24.573 -23.162
    利息收入（费用），非经营净值 0.609 0.583 0.256 0.112 0.071
    税前净收入 -18.95 -22.395 -23.145 -24.461 -23.091
    税后净收入 -18.95 -22.395 -23.145 -24.461 -23.091
    未计算非常项目前的净收益 -18.95 -22.395 -23.145 -24.461 -23.091
    净收入 -18.95 -22.395 -23.145 -24.461 -23.091
    普通股股东可获收益 (不含非经常性项目) -18.95 -22.395 -23.145 -24.461 -23.091
    普通股股东可获收益 (含非經常性項目) -18.95 -22.395 -23.145 -24.461 -23.091
    摊薄净收入 -18.95 -22.395 -23.145 -24.461 -23.091
    摊薄后加权平均股 51.0125 48.7686 48.4484 48.2935 48.1239
    扣除特别项目的每股摊薄盈利 -0.37148 -0.45921 -0.47772 -0.50651 -0.47982
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常摊薄盈利 -0.37148 -0.43672 -0.47772 -0.50651 -0.47982
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流动资产总额 96.967 154.204 224.493 282.78 222.502
    现金和短期投资 91.61 146.627 216.413 274.043 218.08
    现金等价物 52.418 45.627 59.444 46.732 41.471
    短期投资 39.192 101 156.969 227.311 176.609
    Prepaid Expenses 4.413 7.241 6.85 5.363 1.992
    Total Assets 101.794 191.06 283.254 339.907 268.045
    Property/Plant/Equipment, Total - Net 3.938 7.181 10.731 13.805 0.557
    Property/Plant/Equipment, Total - Gross 5.625 8.388 12.567 15.005 1.614
    Accumulated Depreciation, Total -1.687 -1.207 -1.836 -1.2 -1.057
    Goodwill, Net 0 12.638 12.638 12.638
    Intangibles, Net 0 29 29 29
    Long Term Investments 0 27.972
    Total Current Liabilities 16.296 16.073 24.433 24.44 18.472
    Accounts Payable 2.493 2.659 4.598 1.731 3.693
    Accrued Expenses 13.803 13.414 19.835 16.298 9.679
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 19.13 22.131 42.676 66.69 57.392
    Total Long Term Debt 0 0 0 0 0
    Deferred Income Tax 0 2.531 2.531 3.252
    Total Equity 82.664 168.929 240.578 273.217 210.653
    Preferred Stock - Non Redeemable, Net 0 0 0 0
    Common Stock 0.049 0.048 0.034 0.032 0.025
    Additional Paid-In Capital 807.938 800.728 742.387 712.807 552.762
    Retained Earnings (Accumulated Deficit) -724.52 -631.428 -501.573 -439.421 -341.787
    Unrealized Gain (Loss) -0.803 -0.419 -0.27 -0.201 -0.347
    Total Liabilities & Shareholders’ Equity 101.794 191.06 283.254 339.907 268.045
    Total Common Shares Outstanding 48.895 48.1204 34.0267 32.5583 25.4954
    应收账款总额，净额 0.944 0.336 1.23 3.374 2.43
    Accounts Receivable - Trade, Net 0.944 0.336 1.23 3.374 2.43
    Other Current Liabilities, Total 0 6.411 5.1
    Other Liabilities, Total 2.834 6.058 15.712 39.719 35.668
    Other Long Term Assets, Total 0.889 1.703 6.392 1.684 3.348
    Total Preferred Shares Outstanding 0 0 0 0 0
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流动资产总额 79.744 96.967 115.078 124.294 130.777
    现金和短期投资 73.016 91.61 108.651 116.689 123
    现金等价物 43.482 52.418 54.673 43.063 51.174
    短期投资 29.534 39.192 53.978 73.626 71.826
    应收账款总额，净额 0.717 0.944 1.246 0.523 0.524
    Accounts Receivable - Trade, Net 0.717 0.944 1.246 0.523 0.524
    Prepaid Expenses 6.011 4.413 5.181 7.082 7.253
    Total Assets 83.116 101.794 121.516 143.447 162.73
    Property/Plant/Equipment, Total - Net 3.038 3.938 4.825 5.61 6.319
    Goodwill, Net
    Intangibles, Net
    Other Long Term Assets, Total 0.334 0.889 1.613 1.635 2.175
    Total Current Liabilities 9.97 16.296 15.461 14.961 10.709
    Accounts Payable 1.224 2.493 1.942 2.454 1.407
    Accrued Expenses 8.746 13.803 13.519 12.507 9.302
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 12.783 19.13 19.112 19.467 15.939
    Total Long Term Debt 0 0 0 0 0
    Deferred Income Tax
    Other Liabilities, Total 2.813 2.834 3.651 4.506 5.23
    Total Equity 70.333 82.664 102.404 123.98 146.791
    Common Stock 0.052 0.049 0.048 0.048 0.048
    Additional Paid-In Capital 814.264 807.938 805.48 803.91 802.17
    Retained Earnings (Accumulated Deficit) -743.47 -724.52 -702.125 -678.98 -654.519
    Unrealized Gain (Loss) -0.513 -0.803 -0.999 -0.998 -0.908
    Total Liabilities & Shareholders’ Equity 83.116 101.794 121.516 143.447 162.73
    Total Common Shares Outstanding 52.0153 48.895 48.4812 48.3627 48.1329
    Preferred Stock - Non Redeemable, Net 0 0 0 0
    Long Term Investments 0 0 11.908 23.459
    Property/Plant/Equipment, Total - Gross 5.625
    Accumulated Depreciation, Total -1.687
    Total Preferred Shares Outstanding 0 0 0 0 0
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 -93.092 -129.855 -62.152 -97.634 -90.751
    经营活动产生的现金 -84.463 -93.396 -62.957 -84.067 -64.958
    经营活动产生的现金 0.498 0.466 0.691 0.494 0.643
    Deferred Taxes 0 -2.531 0 -0.774 1.099
    非现金物品 10.253 49.925 28.813 23.374 28.256
    营运资金的变化 -2.122 -11.401 -30.309 -9.527 -4.205
    投资活动产生的现金 90.64 26.515 68.07 -50.318 -135.397
    资本支出 -0.102 -3.096 -2.22 -1.554 -0.34
    其他投资现金流量项目，总计 90.742 29.611 70.29 -48.764 -135.057
    融资活动产生的现金 0.614 53.064 7.599 139.646 159.793
    股票的发行（报废），净额 0.614 52.806 6.919 138.899 159.385
    现金净变化 6.791 -13.817 12.712 5.261 -40.562
    融资现金流项目 0.258 0.68 0.747 0.408
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -18.95 -93.092 -70.697 -47.552 -23.091
    Cash From Operating Activities -23.428 -84.463 -65.209 -45.387 -27.502
    Cash From Operating Activities 0.124 0.498 0.374 0.24 0.12
    Non-Cash Items 2.638 10.253 7.458 5.022 2.485
    Changes in Working Capital -7.24 -2.122 -2.344 -3.097 -7.016
    Cash From Investing Activities 10 90.64 74.078 42.646 33.049
    Capital Expenditures -0.102 -0.102 0 0
    Other Investing Cash Flow Items, Total 10 90.742 74.18 42.646 33.049
    Cash From Financing Activities 4.492 0.614 0.177 0.177 0
    Issuance (Retirement) of Stock, Net 4.492 0.614 0.177 0.177 0
    Net Change in Cash -8.936 6.791 9.046 -2.564 5.547
    Deferred Taxes 0
    Financing Cash Flow Items
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.3624 2273762 80800 2023-03-31 LOW
    Satter Management Co., L.P. Private Equity 4.2737 2227500 0 2023-03-31 MED
    Millennium Management LLC Hedge Fund 2.7819 1449987 -47619 2023-03-31 HIGH
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.8881 984105 -50018 2023-03-31 LOW
    Hudson Bay Capital Management LP Hedge Fund 1.8227 950000 -75000 2023-03-31 HIGH
    Platinum Asset Management Investment Advisor/Hedge Fund 1.709 890736 -204034 2023-03-31 LOW
    Renaissance Technologies LLC Hedge Fund 1.4693 765800 262416 2023-03-31 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.8684 452628 0 2023-03-31 LOW
    Federated Hermes MDTA LLC Investment Advisor/Hedge Fund 0.6965 363023 -10613 2023-03-31 MED
    DiMarchi (Richard D) Individual Investor 0.6125 319240 0 2023-04-03
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.5452 284185 -38503 2023-03-31 LOW
    McHutchison (John G) Individual Investor 0.4005 208730 91528 2023-05-23 LOW
    Bridgeway Capital Management, LLC Investment Advisor 0.3338 174000 -14200 2023-03-31
    Fidelity Management & Research Company LLC Investment Advisor 0.3026 157700 11234 2023-03-31 LOW
    Acadian Asset Management LLC Investment Advisor/Hedge Fund 0.3023 157549 -99552 2023-03-31 MED
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.2788 145335 0 2023-03-31 LOW
    Citadel Advisors LLC Hedge Fund 0.2704 140953 32200 2023-03-31 HIGH
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1877 97850 6928 2023-03-31 LOW
    Okazaki (Jason A) Individual Investor 0.1597 83240 28439 2023-05-23 HIGH
    Franklin Advisers, Inc. Investment Advisor/Hedge Fund 0.1586 82645 0 2023-03-31 LOW

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    535K+

    交易者

    87K+

    每月活跃客户

    $113M+

    每月投资额

    $64M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    Assembly Biosciences, Inc. Company profile

    关于 Assembly Biosciences Inc.

    Assembly Biosciences, Inc.是一家处于临床阶段的生物技术公司，正在推进治疗慢性乙型肝炎病毒（HBV）感染的一类口服候选疗法。 公司的候选抑制剂产品包括Vebicorvir（VBR）、ABI-H2158（2158）和ABI-H3733（3733）。 Vebicorvir（VBR）是由印第安纳大学授权，用VBR加核苷酸类似物逆转录酶抑制剂（NrtIs）治疗患者，并最终过渡到患者。 ABI-H2158（2158）在化学上与VBR不同。 ABI-H3733（3733）用于中华人民共和国、香港、台湾和澳门（地区）的慢性HBV感染。 公司的研究和开发项目追求的是抑制HBV复制周期和阻断共价闭合环状DNA（cccDNA）生成的多种候选药物，以发现和开发HBV患者的有限和治愈性疗法。

    Industry: Proprietary & Advanced Pharmaceuticals

    331 Oyster Point Blvd.
    Fourth Floor
    SOUTH SAN FRANCISCO
    CALIFORNIA 94080
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    XRP/USD

    0.52 Price
    -1.270% 1D Chg, %
    多头隔夜费 -0.0753%
    空头隔夜费 0.0069%
    隔夜费时间 21:00 (UTC)
    价差 0.00331

    Oil - Crude

    72.61 Price
    +1.450% 1D Chg, %
    多头隔夜费 -0.0156%
    空头隔夜费 -0.0063%
    隔夜费时间 21:00 (UTC)
    价差 0.03

    BTC/USD

    26,426.70 Price
    -2.060% 1D Chg, %
    多头隔夜费 -0.0616%
    空头隔夜费 0.0137%
    隔夜费时间 21:00 (UTC)
    价差 60.00

    US100

    14,310.90 Price
    -1.780% 1D Chg, %
    多头隔夜费 -0.0255%
    空头隔夜费 0.0032%
    隔夜费时间 21:00 (UTC)
    价差 1.8

    还在找一位您可以信任的经纪商吗？

    加入成为全球535,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易